Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisNEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Newer Agents in the Treatment of Multiple SclerosisNeurologist 19:104-117, Pawate, S. & Bagnato F., 2015